DiaMedica Therapeutics In... (DMAC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

5.38

-0.92%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04
Revenue	-	-	-	-	-	500.00K	-	-	-	-	-	-	-	-	-	-	160.62K	25.74K	25.68K	33.88K
Cost of Revenue	30.00K	25.00K	24.00K	21.00K	21.00K	-	4.00K	2.21K	4.46K	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-30.00K	-25.00K	-24.00K	-21.00K	-21.00K	500.00K	-4.00K	-2.21K	-4.46K	-	-	-	-	-	-	-	160.62K	25.74K	25.68K	33.88K
Operating Income	-21.27M	-14.00M	-13.65M	-12.70M	-11.59M	-6.76M	-4.52M	-2.48M	-1.31M	-4.83M	-7.43M	-10.11M	-6.71M	-3.84M	-2.40M	-1.69M	-2.31M	-787.21K	-203.01K	-603.43K
Interest Income	-	-	-	-	-	-	-	1.73K	1.74K	10.54K	14.73K	41.03K	51.44K	-	-	-	-	-	-	-0.25
Pretax Income	-19.34M	-13.65M	-13.56M	-12.27M	-10.62M	-5.65M	-4.26M	-2.20M	-1.43M	-4.78M	-7.41M	-10.05M	-6.61M	-4.27M	-2.44M	-1.85M	-2.31M	-	-192.73K	-570.16K
Net Income	-19.38M	-13.68M	-13.59M	-12.29M	-10.65M	-5.73M	-4.26M	-2.22M	-1.44M	-4.82M	-7.41M	-10.05M	-6.61M	-4.27M	-2.44M	-1.85M	-2.33M	-778.02K	-210.60K	-640.02K
Selling & General & Admin	8.16M	6.16M	4.88M	4.39M	3.69M	2.74M	1.31M	718.04K	423.35K	1.12M	2.54M	2.53M	2.08M	1.30M	1.00M	618.54K	1.38M	192.37K	177.78K	168.91K
Research & Development	13.11M	7.84M	8.77M	8.31M	7.90M	4.52M	3.21M	1.76M	886.07K	3.71M	3.78M	5.21M	2.33M	803.98K	1.37M	1.04M	1.07M	617.26K	22.75K	462.00K
Other Expenses	-	353.00K	82.00K	-205.00K	-856.00K	-68.00K	6.00K	221.90K	3.00K	-	-	-	-	-	6.58K	-4.89K	-	-	-	-
Operating Expenses	21.27M	14.00M	13.65M	12.49M	10.74M	6.05M	4.28M	2.48M	1.31M	4.83M	7.43M	10.11M	6.71M	3.84M	2.40M	1.69M	2.47M	812.95K	228.69K	637.31K
Interest Expense	-	-	-	-	-	-	-	48.38K	43.95K	-	7.73K	2.72K	12.57K	-	-	-	-	-	7.60K	36.59K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	21.27M	14.00M	13.65M	12.49M	10.74M	6.05M	4.28M	2.48M	1.31M	4.83M	7.43M	10.11M	6.71M	3.84M	2.40M	1.69M	2.47M	812.95K	228.69K	637.31K
Income Tax	43.00K	28.00K	28.00K	27.00K	31.00K	80.00K	-9.00K	22.31K	12.45K	42.28K	7.73K	2.72K	12.57K	499.08K	41.69K	163.43K	20.20K	-9.19K	17.87K	69.86K
Shares Outstanding (Basic)	32.57M	26.44M	20.77M	15.68M	11.99M	7.74M	5.94M	4.74M	3.62M	3.11M	2.73M	2.45M	2.26M	1.43M	960.48K	909.72K	802.30K	876.03K	420.15K	272.16K
Shares Outstanding (Diluted)	32.57M	26.44M	20.77M	15.68M	11.99M	7.74M	5.94M	4.74M	3.62M	3.11M	2.73M	2.45M	2.26M	1.43M	960.48K	909.72K	802.30K	876.03K	420.15K	272.16K
EPS (Basic)	-0.6	-0.52	-0.65	-0.78	-0.89	-0.74	-0.72	-0.47	-0.4	-1.55	-2.71	-4.11	-2.93	-2.98	-2.54	-2.04	-2.91	-0.89	-0.5	-2.35
EPS (Diluted)	-0.6	-0.52	-0.65	-0.78	-0.89	-0.74	-0.72	-0.47	-0.4	-1.55	-2.71	-4.11	-2.93	-2.98	-2.54	-2.04	-2.91	-0.89	-0.5	-2.35
EBITDA	-19.31M	-13.98M	-13.62M	-12.24M	-10.60M	-5.64M	-4.26M	-2.15M	-1.50M	-5.01M	-6.51M	-7.70M	-4.51M	-3.32M	-2.27M	-2.34M	-2.29M	-783.89K	-190.26K	-630.30K
Depreciation & Amortization	30.00K	25.00K	24.00K	21.00K	21.00K	15.00K	4.00K	2.21K	4.11K	2.47K	1.11M	2.37M	2.30M	1.67M	30.20K	26.74K	18.35K	3.32K	28.15K	6.41K